Northern Lights #9 is a modern hybrid strain developed through the cross-breeding of White Widow and Durban. This specific lineage results in a plant that reaches maturity within a 55-day flowering cycle. It is categorized as a moderate-difficulty grow capable of performing well in both indoor and outdoor environments, offering growers the benefit of a high yield. Its genetic potential is demonstrated in its contribution to future breeding projects, most notably seen in the Northern Lights 9 x Skunk 1 cross.

The chemical complexity of Northern Lights #9 is defined by a terpene profile led by myrcene, followed by terpinolene and caryophyllene. Secondary concentrations include limonene, beta-pinene, linalool, and ocimene, with trace amounts of pinene, isopulegol, nerolidol, humulene, guaiol, bisabolol, caryophyllene-oxide, camphene, eucalyptol, p-cymene, and geraniol. This diverse composition informs the strain's sensory profile, balancing heavy botanical notes with a nuanced spectrum of aromatic compounds that characterize its distinct olfactory experience.

As a THC-dominant cultivar, Northern Lights #9 is frequently sought for its ability to induce effects described as relaxed, happy, and uplifted. These qualities make the strain a functional choice for users managing specific conditions such as stress, pain, or difficulties with sleep. By providing a consistent physiological response, the strain serves both recreational and therapeutic needs while maintaining the structural stability expected of its modern hybrid classification.